Strathcona Resources Ltd. Reports Fourth Quarter and Full Year 2025 Financial and Operating Results, Year End Reserves, Announces Quarterly Dividend and Board Approval to Commence Normal Course Issuer
Go back to Strathcona Resources Ltd. Reports Fourth Quarter and Full Year 2025 Financial and Operating Results, Year End Reserves, Announces Quarterly Dividend and Board Approval to Commence Normal Course Issuer| Simcere Pharmaceutical Group (NASDAQ: SCR) | Delayed: 35.58 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $35.58 | 52 Week High | $9.77 | |||
| Open | $21.80 | 52 Week Low | $7.25 | |||
| Day High | $35.58 | P/E | N/A | |||
| Day Low | $35.58 | EPS | $0.00 | |||
| Volume | 21,881 | |||||
